Protein kinase C δ (PKCδ)-extracellular signal-regulated kinase 1/2 (ERK1/2) signaling cascade regulates glycogen synthase kinase-3 (GSK-3) inhibition-mediated interleukin-10 (IL-10) expression in lipopolysaccharide (LPS)-induced endotoxemia

Journal of Biological Chemistry

Volumn 287, Issue 17, 2012, Pages 14226-14233

  Noh, Kyung Tae ^a   Son, Kwang Hee ^a   Jung, In Duk ^a   Kang, Hyun Kyu ^a   Hwang, Sun Ae ^a   Lee, Won Suk ^a   You, Ji Chang ^c   Park, Yeong Min ^b  

^a Pusan National University School of Medicine   (South Korea)

^b Pusan National University   (South Korea)

^c The Catholic University of Korea   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

CELL DIFFERENTIATION; CELLULAR PROCESS; EMBRYONIC DEVELOPMENT; ERK ACTIVATION; EXTRACELLULAR- SIGNAL-REGULATED KINASE 1/2; GLYCOGEN SYNTHASE KINASE-3; INTERLEUKIN-10; LIPOPOLYSACCHARIDES; MITOGEN ACTIVATED PROTEIN KINASE; PROTEIN KINASE C; SEPTIC SHOCKS; SIGNALING CASCADES;

CELL DEATH;

ENZYME ACTIVITY;

GLYCOGEN SYNTHASE KINASE 3; INTERLEUKIN 10; LIPOPOLYSACCHARIDE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MYELOPEROXIDASE; PROTEIN KINASE C DELTA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD PRESSURE MEASUREMENT; CONTROLLED STUDY; CYTOKINE PRODUCTION; DENDRITIC CELL; ENDOTOXEMIA; ENZYME ACTIVATION; ENZYME INDUCTION; ENZYME INHIBITION; HYPOTENSION; IMMUNOMODULATION; MALE; MEAN ARTERIAL PRESSURE; MOUSE; MULTIPLE ORGAN FAILURE; NEUTROPHIL CHEMOTAXIS; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN EXPRESSION; SEPTIC SHOCK;

ANIMALS; BONE MARROW CELLS; DENDRITIC CELLS; ENDOTOXEMIA; GLYCOGEN SYNTHASE KINASE 3; IMMUNE SYSTEM; INTERLEUKIN-10; LIPOPOLYSACCHARIDES; MALE; MICE; MICE, INBRED C57BL; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; PEROXIDASE; PROTEIN KINASE C-DELTA; SIGNAL TRANSDUCTION;

EID: 84859946299     PISSN: 00219258     EISSN: 1083351X     Source Type: Journal    
DOI: 10.1074/jbc.M111.308841     Document Type: Article

References (38)

1. Sriskandan, S., and Altmann, D. M. (2008) The immunology of sepsis. J. Pathol. 214, 211-223 (Pubitemid 351160158)
2. Angus, D. C., Linde-Zwirble, W. T., Lidicker, J., Clermont, G., Carcillo, J., and Pinsky, M. R. (2001) Epidemiology of severe sepsis in the United States. Analysis of incidence, outcome, and associated costs of care. Crit. Care Med. 29, 1303-1310 (Pubitemid 32641789)
3. Dombrovskiy, V. Y., Martin, A. A., Sunderram, J., and Paz, H. L. (2007) Rapid increase in hospitalization and mortality rates for severe sepsis in the United States. A trend analysis from 1993 to 2003. Crit. Care Med. 35, 1244-1250 (Pubitemid 46642649)
4. Martin, G. S., Mannino, D. M., Eaton, S., and Moss, M. (2003) The epidemiology of sepsis in the United States from 1979 through 2000. N. Engl. J. Med. 348, 1546-1554 (Pubitemid 36437931)
5. Bozza, F. A., Salluh, J. I., Japiassu, A. M., Soares, M., Assis, E. F., Gomes, R. N., Bozza, M. T., Castro-Faria-Neto, H. C., and Bozza, P. T. (2007) Cytokine profiles as markers of disease severity in sepsis. A multiplex analysis. Crit. Care 11, R49
6. Castellheim, A., Brekke, O. L., Espevik, T., Harboe, M., and Mollnes, T. E. (2009) Innate immune responses to danger signals in systemic inflammatory response syndrome and sepsis. Scand. J. Immunol. 69, 479-491
7. Peters, K., Unger, R. E., Brunner, J., and Kirkpatrick, C. J. (2003) Molecular basis of endothelial dysfunction in sepsis. Cardiovasc. Res. 60, 49-57 (Pubitemid 38373475)
8. Schwartz, D., Mendonca, M., Schwartz, I., Xia, Y., Satriano, J., Wilson, C. B., and Blantz, R. C. (1997) Inhibition of constitutive nitric-oxide synthase (NOS) by nitric oxide generated by inducible NOS after lipopolysaccharide administration provokes renal dysfunction in rats. J. Clin. Invest. 100, 439-448 (Pubitemid 27349092)
9. Wright, C. E., Rees, D. D., and Moncada, S. (1992) Protective and pathological roles of nitric oxide in endotoxin shock. Cardiovasc. Res. 26, 48-57
10. Bauer, P. R. (2002) Microvascular responses to sepsis. Clinical significance. Pathophysiology 8, 141-148
11. Lam, C., Tyml, K., Martin, C., and Sibbald, W. (1994) Microvascular perfusion is impaired in a rat model of normotensive sepsis. J. Clin. Invest. 94, 2077-2083 (Pubitemid 24348249)
12. Doughty, L., Carcillo, J. A., Kaplan, S., and Janosky, J. (1998) The compensatory anti-inflammatory cytokine interleukin 10 response in pediatric sepsis-induced multiple organ failure. Chest 113, 1625-1631 (Pubitemid 28307169)
13. Gérard, C., Bruyns, C., Marchant, A., Abramowicz, D., Vandenabeele, P., Delvaux, A., Fiers, W., Goldman, M., and Velu, T. (1993) Interleukin 10 reduces the release of tumor necrosis factor and prevents lethality in experimental endotoxemia. J. Exp. Med. 177, 547-550 (Pubitemid 23117107)
14. Howard, M., Muchamuel, T., Andrade, S., and Menon, S. (1993) Interleukin 10 protects mice from lethal endotoxemia. J. Exp. Med. 177, 1205-1208 (Pubitemid 23097411)
15. Steinhauser, M. L., Hogaboam, C. M., Kunkel, S. L., Lukacs, N. W., Strieter, R. M., and Standiford, T. J. (1999) IL-10 is a major mediator of sepsis-induced impairment in lung antibacterial host defense. J. Immunol. 162, 392-399 (Pubitemid 29018946)
16. Tschoeke, S. K., Oberholzer, C., LaFace, D., Hutchins, B., Moldawer, L. L., and Oberholzer, A. (2008) Endogenous IL-10 regulates sepsis-induced thymic apoptosis and improves survival in septic IL-10 null mice. Scand. J. Immunol. 68, 565-571
17. Akira, S., Takeda, K., and Kaisho, T. (2001) Toll-like receptors. Critical proteins linking innate and acquired immunity. Nat. Immunol. 2, 675-680 (Pubitemid 32747155)
18. Hoffmann, J. A., and Reichhart, J. M. (2002) Drosophila innate immunity. An evolutionary perspective. Nat. Immunol. 3, 121-126 (Pubitemid 34141441)
19. Medzhitov, R. (2001) Toll-like receptors and innate immunity. Nat. Rev. Immunol. 1, 135-145
20. Schaeffer, H. J., and Weber, M. J. (1999) Mitogen-activated protein kinases. Specific messages from ubiquitous messengers. Mol. Cell. Biol. 19, 2435-2444 (Pubitemid 29144487)
21. Seger, R., and Krebs, E. G. (1995) TheMAPKsignaling cascade. FASEB J. 9, 726-735
22. Yoon, S., and Seger, R. (2006) The extracellular signal-regulated kinase. Multiple substrates regulate diverse cellular functions. Growth Factors 24, 21-44 (Pubitemid 43108774)
23. Minden, A., and Karin, M. (1997) Regulation and function of the JNK subgroup of MAP kinases. Biochim. Biophys. Acta 1333, F85-F104 (Pubitemid 27509073)
24. Ginnan, R., Guikema, B. J., Singer, H. A., and Jourd'heuil, D. (2006) PKC-δ mediates activation of ERK1/2 and induction of iNOS by IL-1β in vascular smooth muscle cells. Am. J. Physiol. Cell Physiol. 290, C1583-C1591 (Pubitemid 43830798)
25. Wang, Q., Zhou, Y., Wang, X., and Evers, B. M. (2006) Glycogen synthase kinase-3 is a negative regulator of extracellular signal-regulated kinase. Oncogene 25, 43-50 (Pubitemid 43050002)
26. Cohen, P., and Frame, S. (2001) The renaissance of GSK3. Nat. Rev. Mol. Cell Biol. 2, 769-776 (Pubitemid 33679839)
27. Jope, R. S., and Johnson, G. V. (2004) The glamor and gloom of glycogen synthase kinase-3. Trends Biochem. Sci 29, 95-102 (Pubitemid 38186580)
28. Woodgett, J. R. (2001) Judging a protein by more than its name. GSK-3. Sci. STKE 2001, re12
29. Martin, M., Rehani, K., Jope, R. S., and Michalek, S. M. (2005) Toll-like receptor-mediated cytokine production is differentially regulated by glycogen synthase kinase 3. Nat. Immunol. 6, 777-784 (Pubitemid 43090463)
30. Noh, K. T, Park, Y. M., Cho, S. G., and Choi, E. J. (2011) GSK-3β-induced ASK1 stabilization is crucial in LPS-induced endotoxin shock. Exp. Cell Res. 317, 1663-1668
31. Wang, H., Brown, J., Garcia, C. A., Tang, Y., Benakanakere, M. R., Greenway, T., Alard, P., Kinane, D. F., and Martin, M. (2011) The role of glycogen synthase kinase 3 in regulating IFN-β-mediated IL-10 production. J. Immunol. 186, 675-684
32. Kim, J. W., Lee, J. E., Kim, M. J., Cho, E. G., Cho, S. G., and Choi, E. J. (2003) Glycogen synthase kinase 3 β is a natural activator of mitogen-activated protein kinase/extracellular signal-regulated kinase kinase kinase 1 (MEKK1). J. Biol. Chem. 278, 13995-14001 (Pubitemid 36799943)
33. Cavaillon, J. M., Adib-Conquy, M., Fitting, C., Adrie, C., and Payen, D. (2003) Cytokine cascade in sepsis. Scand. J. Infect. Dis. 35, 535-544 (Pubitemid 37336870)
34. Dinarello, C. A. (1997) Proinflammatory and anti-inflammatory cytokines as mediators in the pathogenesis of septic shock. Chest 112, 321S-329S
35. Moore, K. W., O'Garra, A., de Waal Malefyt, R., Vieira, P., and Mosmann, T. R. (1993) Interleukin-10. Annu. Rev. Immunol. 11, 165-190 (Pubitemid 23115005)
36. Latifi, S. Q., O'Riordan, M. A., and Levine, A. D. (2002) Interleukin-10 controls the onset of irreversible septic shock. Infect. Immun. 70, 4441-4446 (Pubitemid 34790955)
37. Song, G. Y., Chung, C. S., Chaudry, I. H., and Ayala, A. (1999) What is the role of interleukin 10 in polymicrobial sepsis. Anti-inflammatory agent or immunosuppressant? Surgery 126, 378-383
38. van der Poll, T., Marchant, A., Buurman, W. A., Berman, L., Keogh, C. V., Lazarus, D. D., Nguyen, L., Goldman, M., Moldawer, L. L., and Lowry, S. F. (1995) Endogenous IL-10 protects mice from death during septic peritonitis. J. Immunol. 155, 5397-5401 (Pubitemid 3015364)